Navigation Links
NBTY to Webcast Presentation at B. Riley & Co. Annual Las Vegas Institutional Investor Conference; Announces Preliminary Unaudited Net Sales Results for February 2009
Date:3/10/2009

RONKONKOMA, N.Y., March 10 /PRNewswire-FirstCall/ -- NBTY, Inc. (NYSE: NTY) (www.NBTY.com), a leading global manufacturer and marketer of nutritional supplements, today announced that it will webcast the presentation by Harvey Kamil, President and Chief Financial Officer of NBTY, at the B. Riley & Co. Annual Las Vegas Institutional Investor Conference on Wednesday, March 18, 2009.

The presentation is scheduled to be webcast live on the Company Web site, www.nbty.com, on Wednesday, March 18, 2009 at 1:00PM Pacific Time (4:00PM Eastern Time).

NBTY's preliminary unaudited net sales results for February 2009 by segment are as follows:

                                    NET SALES
                            (Preliminary and Unaudited)
                             FOR THE MONTH OF FEBRUARY
                                  ($In Millions)

                                             2009     2008   % Change
                                             ----     ----   --------

    Wholesale / US Nutrition                 $111      $81      38%

    North American Retail                     $17      $17       1%

    European Retail                           $42      $51     -18%

    Direct Response / E-Commerce              $17      $19     -10%

    Total                                    $187     $168      12%
                                             ====     ====      ===

Wholesale / US Nutrition net sales for the month of February 2009 include $33 million from Leiner which was acquired in July 2008. Without Leiner sales, the Wholesale / US Nutrition net sales would have decreased 3% for the one-month period. North American Retail same store sales increased 2% for the one month period. European Retail net sales for February 2009 include $7 million from Julian Graves, which NBTY acquired in September 2008. Excluding Julian Graves sales, European Retail net sales decreased 8% in local currency (British Pound Sterling), and 32% in US dollars for the period.

NBTY's preliminary unaudited net sales results for the two months January and February 2009 by segment are as follows:

                                    NET SALES
                            (Preliminary and Unaudited)
                    FOR THE TWO MONTHS OF JANUARY AND FEBRUARY
                                  ($In Millions)

                                             2009     2008   % Change
                                             ----     ----   --------

    Wholesale / US Nutrition                 $220     $164      34%

    North American Retail                     $34      $34       1%

    European Retail                           $88     $107     -18%

    Direct Response / E-Commerce              $38      $40      -6%

    Total                                    $380     $346      10%
                                             ====     ====      ===


Wholesale / US Nutrition net sales for the two-month period of January and February 2009 include $59 million from Leiner which was acquired in July 2008. Without Leiner sales, the Wholesale / US Nutrition net sales would have decreased 2% for the two-month period. North American Retail same store sales increased 2% for the two-month period. European Retail net sales for the two-month period of January and February 2009 include $15 million from Julian Graves, which NBTY acquired in September 2008. Excluding Julian Graves sales, European Retail net sales decreased 8% in local currency (British Pound Sterling), and 32% in US dollars for the two-month period.

ABOUT NBTY

NBTY is a leading global vertically integrated manufacturer, marketer and distributor of a broad line of high-quality, value-priced nutritional supplements in the United States and throughout the world. Under a number of NBTY and third party brands, the Company offers over 22,000 products, including products marketed by the Company's Nature's Bounty(R) (www.NaturesBounty.com), Vitamin World(R) (www.VitaminWorld.com), Puritan's Pride(R) (www.Puritan.com), Holland & Barrett(R) (www.HollandAndBarrett.com), Rexall(R) (www.Rexall.com), Sundown(R) (www.SundownNutrition.com), MET-Rx(R) (www.MetRX.com), Worldwide Sport Nutrition(R) (www.SportNutrition.com), American Health(R) (www.AmericanHealthUS.com), GNC (UK)(R) (www.GNC.co.uk), DeTuinen(R) (www.DeTuinen.nl), LeNaturiste(TM) (www.LeNaturiste.com), SISU(R) (www.SISU.com), Solgar(R) (www.Solgar.com), Good 'n' Natural(R) (www.goodnnatural.com), Home Health(TM) (www.homehealthus.com), Julian Graves, and Ester-C(R) (www.Ester-C.com) brands. NBTY routinely posts information that may be important to investors on its web site.

    Contact:  Harvey Kamil                            Carl Hymans
    NBTY, Inc.                                        G.S. Schwartz & Co.
    President & Chief Financial Officer               212-725-4500
    631-200-2020                                      carlh@schwartz.com

'/>"/>
SOURCE NBTY, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Alexzas Corporate Presentation to be Webcast at the Cowen & Company 29th Annual Health Care Conference
2. Medivation Announces Fourth Quarter and Year-End 2008 Teleconference and Webcast on March 16, 2009
3. Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2008 Financial Results and to Host Conference Call and Webcast on Thursday, March 12, 2009
4. Clarient Reschedules Fourth Quarter and Year-End 2008 Financial Results Release To Wednesday, March 11th; Conference Call and Webcast Rescheduled For 5:00 PM EDT That Day
5. Thoratec Presentation at Raymond James Conference to Be Webcast
6. DiagnoCure to Host Q1 2009 Earnings Conference Call and Webcast
7. Sunrise to Host Conference Call and Webcast to Discuss Fourth-Quarter and Full-Year 2008 Financial Results
8. Volcano Corporation Announces Webcast of February 25th Analyst Day
9. Telik Announces Year-End Financial Release, Conference Call and Webcast
10. Webcast Alert: Usinas Siderurgicas de Minas Gerais S.A. - USIMINAS Announces Fourth Quarter 2008 Earnings Results Webcast
11. Webcast Alert: Genomma Lab Announces Fourth Quarter 2008 Earnings Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... WASHINGTON, D.C., (PRWEB) , ... April 28, 2016 ... ... health systems, and the Campaign for Tobacco-Free Kids, a leading force in the ... to promote federal, state and local policies that can help reduce tobacco use. ...
(Date:4/28/2016)... NJ (PRWEB) , ... April 28, 2016 , ... ... BCBNSNJ), which is has been collaborating with doctors and hospitals to make transformative ... join the world’s leading cell therapy minds this week in discussing breakthroughs in ...
(Date:4/28/2016)... ... ... Amada Senior Care, premier provider of non-medical in-home care and assisted living ... West location. Prior to entering the senior care industry, Amada franchise partner Rick Stockton ... Antonio West will take place on Friday, April 29th. , Rick said ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... the development of miniature microphones and headsets announced today that the US Patent ... of integrating in-earphones into a structure. This innovative design creates a lightweight and ...
(Date:4/28/2016)... , ... April 28, 2016 , ... Metabolic Nutrition ... GlycoLoad at this week’s 2016 Europa Games Get Fit and Sports Expo ... alike, the Europa Orlando Expo coming up April 29-30, was selected as the perfect ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... NEW YORK , April 28, 2016  The ... reached 275 million dollars, according to Kalorama Information and ... includes typing, immunoassays and nucleic acid testing.  The healthcare ... had made progress in developing blood collection stations and ... was made in Kalorama Information,s report, Blood ...
(Date:4/28/2016)... 28, 2016   Acsis , a leading provider ... IT market research and advisory firm IDC has named ... MarketScape: Worldwide Pharmaceutical Track and Trace Software 2016 Vendor ... an assessment of the capabilities and business strategies of ... market. Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/27/2016)... , Schweiz, April 27, 2016 ... Sachs CEO Forums in Zürich gab Strekin ... führenden Wirkstoffkandidaten STR001 zur Erhaltung des Resthörvermögens ... wurde, bekannt. Für die umfassende Phase-II-Doppelblindstudie mit ... Frankreich angeworben. STR001 wird während der Operation ...
Breaking Medicine Technology: